Search for a research project
Other search option(s)
154 Result(s)
Funded by an IRDiRC member = Member of a ERN =
Research projects

Hessen
GIEßEN
Barrier free chromatic pupillometry in children from infancy on. A novel biomarker to quantify outer and inner retinal function in inherited retinal disorders as a measure of therapeutic benefit after gene therapy (SPP 2127: Gene and cell based therapies to counteract neuroretinal degeneration)
Augenklinik des UKGM am Standort Gießen
Klinik und Poliklinik für Augenheilkunde

County Dublin
DUBLIN
Exploration of theraputic strategies for ocular disorders
Trinity College Dublin
Smurfit Institute of Genetics

GRAND-EST
STRASBOURG
Retinis Pigmentosa: validation of the molecular diagnostic using next generation sequencing
CHU de Strasbourg - Hôpital Civil
Laboratoire de diagnostic génétique

ILE-DE-FRANCE
PARIS
Epidemiological study in hereditary dystrophies of retina
Institut de la Vision
Centre d'Investigation Clinique (CIC) de l'hôpital des Quinze-Vingts

ILE-DE-FRANCE
PARIS
Research of drugs and therapeutic targets for rare retinal dystrophies using cell models from patients
Institut de la Vision
Centre de Recherche Institut de la Vision

OCCITANIE
MONTPELLIER
Gene therapy of retinal dystrophy on human models: differentiation of patients iPS cells to retinal cells
Hôpital Saint Eloi - Bâtiment INM
Equipe "Génétique et thérapie des cécités rétiniennes et du nerf optique"

OCCITANIE
MONTPELLIER
Developing and studying the effects of innovative therapies for rare inherited retinal disease using human retinal models derived from patient iPS cells
Hôpital Saint Eloi - Bâtiment INM
Equipe "Génétique et thérapie des cécités rétiniennes et du nerf optique"

County Dublin
DUBLIN
Target 5000: A Study of Inherited Retinal Degeneration
Mater Misericordiae Hospital
Department of Ophthalmology

County Dublin
DUBLIN
Target 5000: A Study of Inherited Retinal Degeneration
Royal Victoria Eye and Ear Hospital
Ophthalmology Research Department

County Dublin
DUBLIN
Target 5000: A Study of Inherited Retinal Degeneration
Trinity College Dublin
Smurfit Institute of Genetics

Alberta
EDMONTON
Choroideremia, Expanding our Understanding, Exploring Treatments
University of Alberta
CHM

Finland
HELSINKI
CRMCC (cerebroretinal microangiopathy with calcifications and cysts)
HUS - Helsinki University Hospital
New Children's Hospital

Baden-Württemberg
TÜBINGEN
TargetRD: PKG and CNGC as targets for mutation-independent therapy for inherited retinal degeneration.
Department für Augenheilkunde Tübingen
Forschungsinstitut für Augenheilkunde

Baden-Württemberg
TÜBINGEN
SOLSTICE: A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Retinal Gene Therapy in Subjects With Choroideremia Treated Previously With Adeno-Associated Viral Vector Encoding Rab Escort Protein-1 (AAV2-REP1) in an Antecedent Study
Department für Augenheilkunde Tübingen
Universitäts-Augenklinik

Bremen
BREMEN
TargetRD: PKG and CNGC as targets for mutation-independent therapy for inherited retinal degeneration.
Biolog Life Science Institute GmbH & Co. KG
Biolog Life Science Institute

Hessen
KASSEL
TargetRD: PKG and CNGC as targets for mutation-independent therapy for inherited retinal degeneration.
Universität Kassel
Department of Biochemistry

Andalucía
SEVILLA
Biomedical research and clinical innovation in hereditary retinal dystrophies: towards personalized medicine in rare diseases
Hospital Universitario Virgen del Rocío
Unidad de Medicina Maternofetal, Genética y Reproducción

Madrid
MADRID
Deciphering the molecular basis of ophtalmogenetic diseases: sequencing the whole genome using a long reads approach - ES
Fundación Jiménez Díaz
Área de Genética y Genómica

Region Västra Götaland
GÖTEBORG
Molecular defence against retinopathy of prematurity: screening, prevention and treatment
The Queen Silvia Children's Hospital - Sahlgrenska
Department of clinical neurosciences

California
BERKELEY
Role of nrf2 in retinal vascularization and rop
University Of California Berkeley
Ophthalmology

Washington
ADDRESS: NOT PROVIDED - US
The molecular basis of liver induced retinal blood vessel plasticity.
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Analyzing retinal microanatomy in retinopathy of prematurity to improve care
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Genetic modifiers of retinal disease
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Pathogenic role of epac1 signaling in retinopathy of prematurity
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Retinal neurovascular patterning in preterm infants
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Genomic analysis in genes responsible for eye abnormalities in patients
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Inherited ocular diseases
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
National ophthalmic disease genotyping and phenotyping network - eyegene
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Proteins from hereditary eye diseases: in silico and experimental studies
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Ibuprofen-caffeine modulation of retinal endothelial tip cell migration
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Neonatal translational
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Ocular nsaids/caffeine potentiation in oxygen-induced retinopathy
Institution: Information not provided - US

OOST-VLAANDEREN
GENT
Characterisation of genes and molecular mechanisms involved in hereditary connective tissue diseases by studying transgenic animal models and human tissues
Center for Medical Genetics Gent
Centrum voor Medische Genetica - UZ Gent

ILE-DE-FRANCE
EVRY
Stem cell Therapy for Retinal Epithelium replacement Assay in Monogenic retinopathies
GENOPOLE - Campus 1
I-Stem - Institut des cellules Souches pour le Traitement et l'Etude des maladies Monogéniques

Bayern
REGENSBURG
Understanding the basic pathology of BEST1-associated bestrophinopathies and seeking therapeutic compounds to ameliorate the deleterious effects on vision
Universitätsklinikum Regensburg
Zentrum für Humangenetik Regensburg

Saarland
HOMBURG
Visual impairment and blindness in multiple-handicapped children
Universitätsklinikum des Saarlandes
AG Kinder- & Neuroophthalmologie

Galicia
VIGO
Molecular mechanisms in ciliopathies
Universidade de Vigo
Grupo de Enfermedades raras

Region Stockholm
STOCKHOLM
Understanding Genetic Mechanisms in Disorders and Development of Diagostic Methods
Karolinska Institutet - Solna
Department of Molecular Medicine and Surgery

West Midlands
BIRMINGHAM
EURO-WABB: EURO-Rare Diabetes Project (coordination)
Birmingham Children's Hospital NHS Foundation Trust
Diabetes Unit

Washington
ADDRESS: NOT PROVIDED - US
Wnt signaling-mediated control of blood-retinal barrier
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Evaluation of interferon gamma-1b administered topically for macular edema/intraretinal schisis cysts in rod-cone dystrophy (rcd) & enhanced s-cone syndrome (escs)
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Generation of induced pluripotent stem (ips) cell lines from somatic cells of participants with eye diseases and from somatic cells of matched controls
Institution: Information not provided - US

TIROL
INNSBRUCK
Pharmacotherapeutic potential Cav1.4 calcium channels
Universität Innsbruck
Institut für Pharmazie

Ontario
TORONTO
Molecular regulation of progenitor cell behaviour in the developing retina
University of Toronto
Cell & Systems Biology

Finland
JYVÄSKYLÄ
Usherin oireyhtymää sairastavien ja heidän perheidensä psyykkinen jaksaminen
University of Jyväskylä
Department of Psychology

GRAND-EST
STRASBOURG
Bardet-Biedl syndrome: new genes identification and biological characterization of a new gene BBS10
Faculté de médecine de Strasbourg - Louis Pasteur
Laboratoire de génétique médicale - Unité Inserm U1112

ILE-DE-FRANCE
EVRY
Retinal tissue engineering from human pluripotent stem cells for the treatment of retinal dystrophies
GENOPOLE - Campus 1
I-Stem - Institut des cellules Souches pour le Traitement et l'Etude des maladies Monogéniques

ILE-DE-FRANCE
PARIS
Animal model creation of Stargardt disease by interfering RNA
Hôpital Necker-Enfants Malades
Génétique et épigénétique des maladies métaboliques, neurosensorielles et du développement

ILE-DE-FRANCE
PARIS
Decoding the genetic of Leber congenital amaurosis and progression of the therapeutic approach by exon skipping of the major mutation of the CEP290 gene
Hôpital Necker-Enfants Malades
Génétique et épigénétique des maladies métaboliques, neurosensorielles et du développement

ILE-DE-FRANCE
PARIS
Hereditary dystrophies of retina: physiopathologic and clinic research
Institut de la Vision
Centre d'Investigation Clinique (CIC) de l'hôpital des Quinze-Vingts

ILE-DE-FRANCE
PARIS
Hereditary dystrophies of retina: pharmacological research and new therapeutics development (cell and gene therapies)
Institut de la Vision
Centre d'Investigation Clinique (CIC) de l'hôpital des Quinze-Vingts

ILE-DE-FRANCE
PARIS
eyePS: Modeling and treatment of retinal dystophies with iPS cells - FR
Institut de la Vision
Centre de Recherche Institut de la Vision

OCCITANIE
MONTPELLIER
Genetics of autosomal recessive retinitis pigmentosa and of macular dystrophies
Hôpital Saint Eloi - Bâtiment INM
Equipe "Génétique et thérapie des cécités rétiniennes et du nerf optique"

OCCITANIE
MONTPELLIER
Dominant autosomic retinitis pigmentosa: prevalence of known genes and identification of new ones
Hôpital Saint Eloi - Bâtiment INM
Equipe "Génétique et thérapie des cécités rétiniennes et du nerf optique"

PAYS DE LA LOIRE
NANTES
GT-AAVRPGRIP: evaluation of a recombinant Adeno-Associated Vector serotype 5 (rAAV-5) vector for the gene replacement therapy of a new canine model of Leber congenital amaurosis (LCA) : the Dachshund dog RPGRIP-/-
CHU de Nantes - Hôtel Dieu
Vecteurs viraux et transfert de genes in vivo

PAYS DE LA LOIRE
NANTES
Development of a preclinical rat model of RDH12 -/- (congenital Leber amaurosis ) and characterization of its clinical phenotype
CHU de Nantes - Hôtel Dieu
Vecteurs viraux et transfert de genes in vivo

PAYS DE LA LOIRE
NANTES
Evaluation of the immune response in Briards dogs RPE65 -/- treated with gene therapy
CHU de Nantes - Hôtel Dieu
Vecteurs viraux et transfert de genes in vivo

Baden-Württemberg
TÜBINGEN
Genetics and pathophysiology of autosomal recessive achromatopsia
Department für Augenheilkunde Tübingen
Molekulargenetisches Labor

Baden-Württemberg
TÜBINGEN
Molecular genetic basis of BCM and the genetic mechanisms underlying the occurrence of mutations in the opsin gene cluster
Department für Augenheilkunde Tübingen
Molekulargenetisches Labor

Baden-Württemberg
TÜBINGEN
Selecting the right patients for gene therapy: Development and implementation of a pathogenicity scoring system combined with functional in vitro and in vivo validation of gene variants and genotypes in patients with inherited retinal dystrophies as a criterium for the eligibility for gene therapy (SPP 2127)
Department für Augenheilkunde Tübingen
Molekulargenetisches Labor

Baden-Württemberg
TÜBINGEN
Molecular genetic basis of BCM and the genetic mechanisms underlying the occurrence of mutations in the opsin gene cluster
Department für Augenheilkunde Tübingen
Molekulargenetisches Labor

Baden-Württemberg
TÜBINGEN
European Training Network to Diagnose, Understand and Treat Stargardt Disease, a Frequent Inherited Blinding Disorder (partner DE)
Department für Augenheilkunde Tübingen
Molekulargenetisches Labor

Baden-Württemberg
TÜBINGEN
Rate of Progression in USH2A Related Retinal Degeneration
Department für Augenheilkunde Tübingen
Universitäts-Augenklinik

Berlin
BERLIN
Identification of molecular mechanisms acting at the jObes1 locus in the Berlin Fat Mouse with effect on juvenile fat deposition
Humboldt-Universität zu Berlin
Fachbereich Züchtungsbiologie und molekulare Genetik

Hessen
GIEßEN
Natural History Study of CEP290-Related Retinal Degeneration
Augenklinik des UKGM am Standort Gießen
Klinik und Poliklinik für Augenheilkunde

Rheinland-Pfalz
MAINZ
Characterization of the retinal phenotype and pre-clinical evaluation of AAV mediated gene augmentation in the transgenic USH1C pig
Institut für Zoologie der Universität Mainz
Institut für Zoologie - Abt. I - AG Wolfrum

Rheinland-Pfalz
MAINZ
VLGR1 signaling at focal adhesions and ICD release as a non-canonical signaling pathway of aGPCRs
Institut für Zoologie der Universität Mainz
Institut für Zoologie - Abt. I - AG Wolfrum

Sachsen
DRESDEN
EXOSC2 zebrafish model and exosom : analysis of EXOSC2 in the development of HK syndrome
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Institut für Klinische Genetik

County Dublin
DUBLIN
Inherited childhood sight loss: understanding visual cycle biology to develop treatments
University College Dublin
UCD Conway Institute of Biomolecular and Biomedical Research

LAZIO
ROMA
Understanding molecular basis for Inherited Retinal Diseases (IRDs)
ISS - Istituto Superiore di Sanità
Centro Nazionale per la Ricerca e la Valutazione preclinica e clinica dei Farmaci

LIGURIA
GENOVA
Development and application of optoneural prosthetic devices as a therapeutic approach for Retinitis pigmentosa
IRCCS Ospedale Policlinico San Martino - IST - DIMI
Dipartimento di Medicina Sperimentale

TOSCANA
PISA
Cone dystrophies and retinal degeneration from protein structures to biological networks. Toward the design of therapeutic molecules
Università degli Studi di Pisa-Istituto di Fisiologia
Istituto di Fisiologia

VENETO
VERONA
Cone dystrophies and retinal degeneration from protein structures to biological networks. Toward the design of therapeutic molecules
Università degli Studi di Verona
Dipartimento di Neuroscienze, Biomedicina e Movimento

JAPAN
MIYAGI
Intensive genetic analysis and elucidation of the pathology by genome editing aiming at gene-specific treatment for retinitis pigmentosa
Tohoku University Graduate School of Medicine
Department of Advanced Ophthalmic Medicine

JAPAN
OKAYAMA
Manufacture and quality control, first-in-human feasibility study as investigator (doctor)-initiated clinical trial for Okayama University-type retinal prosthesis (OUReP)
Okayama University Medical School
Department of Ophthalmology

JAPAN
TOKYO
Omics analysis to identify disease-causing mutation and molecular mechanism of inherited retinal diseases, inherited glaucoma and inherited optic neuropathy
National Hospital Organization Tokyo Medical Center
National Institute of Sensory Organs

KOREA, REPUBLIC OF
KOREA
Integrative study of epigenetic variations in rare diseases
Korea National Institute of Health

KOREA, REPUBLIC OF
SEOUL
Study on the effects of mutations under inherited retinal disease in Korean
Yonsei University College of Medicine

Gelderland
NIJMEGEN
Identification of the genetic causes of inherited retinal dystrophies
Radboudumc - Radboud universitair medisch centrum
Afdeling Genetica

Gelderland
NIJMEGEN
TREATCilia: Novel Therapeutic Avenues for dynein-related Ciliopathies
Radboudumc - Radboud universitair medisch centrum
Afdeling Genetica

Gelderland
NIJMEGEN
Identification of the genetic causes of inherited retinal dystrophies
Radboudumc - Radboud universitair medisch centrum
Afdeling Oogheelkunde

Noord-Holland
AMSTERDAM
A retinal origin of congenital nystagmus
Nederlands Herseninstituut

Andalucía
SEVILLA
Mathematical models of disease mechanisms to reformulate drugs for rare diseases
Fundación Progreso y Salud
Área de bioinformática clínica

Cataluña
BARCELONA
Mitochondrial and metabolic dynamics in a retinitis pigmentosa model. A new therapeutic approach?
Universitat de Barcelona. Facultat de Biologia
Departamento de Genética, Biología y Estadística

Comunidad Valenciana
VALENCIA
Development of anti-inflammatory nanotherapies for retinitis pigmentosa
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de investigación en biomedicina molecular, celular y genómica

Madrid
MADRID
Lost heritability in sRP and LCA cases. Search for CNVs and new variants
Fundación Jiménez Díaz
Área de Genética y Genómica

Madrid
MADRID
Retinal Dystrophies: genomic, cellular, functional and bioinformatic approaches to accelerate their diagnosis and treatment and to measure their impact
Hospital Universitario Fundación Jiménez Díaz
Servicio de Genética Clínica

Region Skåne
LUND
Retinal transplantation: strategies for clinical therapy of Retinitis pigmentosa
Lund University
Division of Ophthalmology

Region Stockholm
STOCKHOLM
Genetic and molecular mechanisms in familial visual impairment
Karolinska Institutet - Solna
Department of molecular medicine and surgery

Greater London
LONDON
The role of transcription factors in regulating expression of BBS (Bardet-Biedl Syndrome) proteins
GOSH NHS Foundatin Trust
Molecular Medicine Unit

Oxfordshire
HEADINGTON
Development of novel tests to assess visual function in patients with inherited retinal degeneration.
John Radcliffe Hospital, University of Oxford
Nuffield Department of Clinical Neurosciences

California
BERKELEY
Function of ciliary disease protein retinitis pigmentosa gtpase regulator (rpgr)
University Of California Berkeley
Ophthalmology

California
SAN FRANCISCO
Cortical structure and function in blindness and following restored vision
University Of California, San Francisco
Neurology

South Carolina
COLUMBIA
Rate of Progression in USH2A Related Retinal Degeneration
Foundation Fighting Blindness
Foundation Fighting Blindness USA

Washington
ADDRESS: NOT PROVIDED - US
Preclinical innovation
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Drug repurposing screening for rare and neglected diseases
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Genetic epidemiology of complex diseases
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Drug discovery and mechanistic study of p23h rhodopsin associated retinitis pigmentosa
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
The role of complement in recessive stargardt disease
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Large animal therapy studies
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Broad-band opsin and targeted optical-delivery for retinitis pigmentosa treatment
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Cilium-associated structures in rod cells
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Cone rescue in retinitis pigmentosa
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Crumbs proteins for photoreceptor development and health maintenance
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Development of allele independent gene therapy strategies for autosomal dominant retinitis pigmentsa
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Mechanism of death of bystander retinal cells during mcmv infection
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Mechanistic studies on regenerative medicine approaches to childhood blindness
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Neuroprotective mechanisms of inosine monophosphate dehydrogenase inhibitors in retinitis pigmentosa
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Non-hydrolysable analogs of retinal chromophore; potential new therapeutics to prevent retinal degeneration
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Novel imaging of rod oxidative stress in retinal disease and treatment in vivo
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting retinitis pigmentosa using nanoparticle-mediated delivery of genomic dna
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Function of c8orf37 in photoreceptors
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Imaging the functional biomarker of photoreceptors
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Modulation of lipid bisretinoids clearance with beta-cyclodextrins
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Noninvasive assessment of pathophysiology in retinitis pigmentosa
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Role of microglia in retinitis pigementosa
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
The role of arap1 in retinal photoreceptor homeostasis
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Use of systems pharmacology to prevent rod and cone photoreceptor degeneration
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Color vision in inherited retinal degenerations
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Disease mechanism and therapies for retinal degeneration
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Human rhodopsin-adrp studies
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Interventional approaches for restoring vision
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Large animal (dog) experimental support module
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Mechanisms of retinal degeneration in inherited diseases
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Molecular genetics of early eye development
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
The focal electro-oculogram in macular disease
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Retinal gene therapy
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Preclinical safety studies
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Retinal aging and inherited neurodegenerative diseases
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Neuroendocrine regulation of metabolism and neurocognition
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Physiology; psychology; and genetics of obesity
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Reciprocal signaling in synaptogenesis
Institution: Information not provided - US

ILE-DE-FRANCE
PARIS
Modeling the Usher Syndrome type I (USH1) retinopathy in pig: physiopathology and gene therapy
Institut Pasteur
Génétique et Physiologie de l'audition - Inserm U1120 Paris 6

Bayern
REGENSBURG
Allele-specific suppression of pathogenic Bestrophin-1 transcripts by targeted CRISPR/Cas9-mediated genome editing
Universitätsklinikum Regensburg
Zentrum für Humangenetik Regensburg

Madrid
MADRID
A Multicentre Longitudinal, Observational Natural History Study to Evaluate Disease Progression in Subjects With Usher Syndrome Type 1B (USH1B) - ES
Fundación Jiménez Díaz
Área de Genética y Genómica

Washington
ADDRESS: NOT PROVIDED - US
Therapeutic genome editing to treat best disease
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Natural history and genetic studies of usher syndrome
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Pilot study to evaluate oral minocycline in the treatment of cystoid macular edema associated with retinitis pigmentosa
Institution: Information not provided - US
Multicentric Research projects
- EEIG - EUROPEAN VISION INSTITUTE
- EUROPEAN VISION INSTITUTE
- Institut de la Vision
- Centre d'Investigation Clinique (CIC) de l'hôpital des Quinze-Vingts
- The Queen Silvia Children's Hospital - Sahlgrenska
- Department of clinical neurosciences
- St Mary's Hospital
- Manchester Cente for Genomic Medicine
- Birmingham Women's NHS Foundation Trust
- Medical and Molecular Genetics, Norton Court
- University of Birmingham
- Department of Medical and Molecular Genetics
- GENOPOLE - Campus 1
- I-Stem - Institut des cellules Souches pour le Traitement et l'Etude des maladies Monogéniques
- Centre hospitalier national d'ophtalmologie des Quinze-Vingts
- Centre de Référence REFERET
- Institut Pasteur
- Génétique et Physiologie de l'audition - Inserm U1120 Paris 6
- Institut Pasteur
- Génétique et Physiologie de l'audition - Inserm U1120 Paris 6
- Institut de la Vision
- Centre d'Investigation Clinique (CIC) de l'hôpital des Quinze-Vingts
- Institut de la Vision
- Centre de Recherche Institut de la Vision
- Université Pierre et Marie Curie - Paris 6
- Département Traitement des Informations Visuelles
- Department für Augenheilkunde Tübingen
- Forschungsinstitut für Augenheilkunde
- Institut für Zoologie der Universität Mainz
- Institut für Zoologie - Abt. I - AG Wolfrum
- TIGEM - Telethon Institute of Genetics and Medicine
- Laboratorio di Ricerca

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUXELLES
EuroVisionNet: Slechtziendheid en Degeneratie: Een draaiboek voor onderzoek naar gezichtsvermogen in Europe (AFGEROND)

ILE-DE-FRANCE
PARIS
EVI-GENORET: functional genomics of the retina in health and disease (FINISHED)

Region Västra Götaland
GÖTEBORG
PREVENTROP: New approach to treatment of the blinding disease Retinopathy of Prematurity (ROP)

Greater Manchester
MANCHESTER
NIMBL: Nuclease Immune Mediated Brain and Lupus-like conditions (NIMBL): natural history, pathophysiology, diagnostic and therapeutic modalities with application to other disorders of autoimmunity (TERMINATED)

West Midlands
BIRMINGHAM
National Autozygosity Mapping Resource

West Midlands
BIRMINGHAM
National Autozygosity Mapping Resource

ILE-DE-FRANCE
EVRY
SightREPAIR: Preclinical validation of a stem cell-derived retinal pigmented epithelium for treatment of retinal degenerative diseases

ILE-DE-FRANCE
PARIS
RHORCOD: comprehensive analysis of rod-cone photoreceptor degeneration associated with Rhodopsin gene mutations

ILE-DE-FRANCE
PARIS
Réseau sur les surdités héréditaires

ILE-DE-FRANCE
PARIS
TREATRUSH: fighting blindness of Usher syndrome: diagnosis, pathogenesis and retinal treatment

ILE-DE-FRANCE
PARIS
RDCVF: rod-derived cone viability factor (TERMINATED)

ILE-DE-FRANCE
PARIS
eyePS: Modeling and treatment of retinal dystophies with iPS cells

ILE-DE-FRANCE
PARIS
OPTOREMODE: Retinitis Pigmentosa diagnosis and therapy: retinal remodeling and optogenetic reactivation of degenerated retina

Baden-Württemberg
TÜBINGEN
DRUGSFORD: Preclinical development of drugs and drug delivery technology for the treatment of inherited photoreceptor degeneration

Rheinland-Pfalz
MAINZ
Eur-USH: European young investigators network for Usher syndrome

CAMPANIA
NAPOLI